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Abstract
Advanced glycation end-products (AGE) contribute to age-related connective tissue damage and functional deficit. The
documented association between AGE formation on collagens and the correlated progressive stiffening of tissues has
widely been presumed causative, despite the lack of mechanistic understanding. The present study investigates precisely
how AGEs affect mechanical function of the collagen fibril – the supramolecular functional load-bearing unit within most
tissues. We employed synchrotron small-angle X-ray scattering (SAXS) and carefully controlled mechanical testing after
introducing AGEs in explants of rat-tail tendon using the metabolite methylglyoxal (MGO). Mass spectrometry and collagen
fluorescence verified substantial formation of AGEs by the treatment. Associated mechanical changes of the tissue
(increased stiffness and failure strength, decreased stress relaxation) were consistent with reports from the literature. SAXS
analysis revealed clear changes in molecular deformation within MGO treated fibrils. Underlying the associated increase in
tissue strength, we infer from the data that MGO modified collagen fibrils supported higher loads to failure by maintaining
an intact quarter-staggered conformation to nearly twice the level of fibril strain in controls. This apparent increase in fibril
failure resistance was characterized by reduced side-by-side sliding of collagen molecules within fibrils, reflecting lateral
molecular interconnectivity by AGEs. Surprisingly, no change in maximum fibril modulus (2.5 GPa) accompanied the
changes in fibril failure behavior, strongly contradicting the widespread assumption that tissue stiffening in ageing and
diabetes is directly related to AGE increased fibril stiffness. We conclude that AGEs can alter physiologically relevant failure
behavior of collagen fibrils, but that tissue level changes in stiffness likely occur at higher levels of tissue architecture.
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Introduction
Aging is associated with a progressive stiffening of connective
tissues of the body. These include hard connective tissues of the
skeleton [1,2] and soft tissues of the cardiovascular system [3],
lungs [4], skin [5] and tendons [6]. The stiffening of tissue cannot
be explained by increased collagen content alone [3,6] and is
accompanied by age-associated yellowing of the collagen matrix,
decreased collagen solubility, and heightened collagen resistance
to protease breakdown. Certain metabolic diseases, particularly
diabetes, accelerate these phenomena that have been causally
linked to non-enzymatic glycation of proteins [7–10]. Protein
glycation ultimately leads to the formation of advanced glycation
end-products (AGEs), with inter- and intra-molecular AGE cross-
links suspected to affect molecular and cellular function, with
according functional consequences at the tissue level. The
biochemical reactions involved in AGE formation are well
documented, as are AGE stimulated cellular production of
reactive oxygen species, and the activation of inflammatory
signaling cascades via AGE signaling receptors (RAGEs) [11].
Together with changes in tissue elasticity and associated changes
in the mechanical stimuli that drive resident cell behavior, these
factors may play a crucial role in loss of tissue homeostasis and
progression of connective tissue disease.
AGEs are formed when endogenous carbonyl groups of
reducing sugars non-enzymatically react with free amino groups
of proteins. Although glucose is relatively slow in reacting with
most proteins, highly reactive dicarbonyl compounds are gener-
ated upon glucose auto-oxidation. Dicarbonyls can also form as
metabolic by-products of glycolysis including the products glyoxal,
methylglyoxal (MGO) and 3-deoxyglucosone, all of which can
interact with extracellular proteins to rapidly form AGEs [12]. So
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far, there is no direct experimental evidence linking AGEs with
increases in collagen fibril stiffness, which in turn would cause
increased stiffness at higher levels of tissue architecture. Although
the mechanical effects of AGEs at the molecular and supramo-
lecular levels are poorly understood, this link seems plausible and
has been widely presumed to exist on the basis of the well
documented correlation between AGE markers (pentosidine; auto-
fluorescence) and increasing tissue stiffness [13].
Collagen molecules are composed of triple helical amino acid
chains that form a molecular unit with an approximate diameter of
1.5 nm and length of 300 nm. These molecules aggregate into
collagen fibrils (functional supramolecular structures with diame-
ters of 10–500 nm) adopting a so-called ‘‘quarter-stagger’’ model
that yields the characteristic fibril striation that can be seen in
electron micrographs (Fig. 1). This pattern is due to the length of
each collagen molecule being 4.4 times that of the periodic
striation (D%67 nm). The consequence of this geometric config-
uration is a gap of approximately 0.54 D length between the ends
of successive collagen molecules. These nano-scale distances can
be measured by small-angle X-ray scattering (SAXS) to assess
molecular deformations during mechanical loading [14–16]. Past
measurements have employed SAXS to estimate collagen mole-
cule [17] and fibril stiffness [18]. Measurements of the deforma-
tions underlying collagen fibril elongation are generally considered
to reflect the cumulative effects of molecular elongation (i.e.
‘‘strain’’) and side-by-side sliding of molecules [15,18] (Fig. 2).
Experiments and models have shown that both of these
phenomena are strongly dependent upon enzymatic lysyl oxidase
(LOX) cross-links between neighboring collagen molecules [19–
21].
In contrast to the enzymatic cross-links involved in tissue
maturation, very little evidence exists regarding the molecular-
level mechanical effects of stochastically distributed non-enzymatic
cross-links (AGEs) in collagen. While an atomistic model was
recently used to predict preferential sites of AGE cross-links [22],
the role of AGEs has been mostly explored at the tissue level. For
instance, increasing AGE content has been correlated to reduced
bone toughness and increased fracture risk, a relationship that has
been demonstrated experimentally [23,24] and through numerical
modeling [25].
The goal of the present investigation was to more directly
quantify the mechanical consequences of AGEs on collagen fibril
failure behavior and viscoelasticity. This study employed synchro-
tron small-angle X-ray scattering and mechanical testing to reveal
how collagen fibril deformations are altered by MGO induced
AGEs in rat tail tendon fascicles. The rat tail tendon fascicle is a
widely employed experimental model to study collagen structure-
function, and was previously employed by us to characterize the
effects of AGEs on collagen fiber kinematics at the cellular scale
(,10 spatial resolution) using multiphoton confocal microscopy
[26]. In this earlier work, we observed drastically diminished
tendon viscoelasticity in MGO treated tendons and a correspond-
ing loss of collagen fiber sliding. The mechanisms behind this
potentially critical functional loss remained unclear. The intent of
the present study was to focus on the underlying molecular effects
of AGEs, hoping to gain mechanistic insight into these functional
deficits that may underlie loss of tissue homeostasis and play a
central role in tissue disease.
Results
Tissue mechanical effects of MGO
Consistent with our previous study [26], tissue stiffness and
stress relaxation were heavily affected in rat tail tendon fascicles
treated with highly purified MGO to induce formation of AGEs
[27] (for details on MGO synthesis and quality control see: Figure
S1). Dissected fascicles were incubated for 6 h, 24 h or 96 h in
either 30 mM MGO solution or in buffer only. Subsequent quasi-
static mechanical tests revealed that mechanical properties were
most changed after the first 6 h of treatment, with only
incremental additional effects afterward (analysis of variance
(ANOVA): p,0.001) (Fig. 3). We observed a significant increase
of elastic modulus by 35% in the linear range of the stress-strain
curve (post hoc: p = 0.03) (Fig.: 3 B1). Ultimate tensile strength
increased by 110% after 6 h of treatment (post hoc: p = 0.03) with
no significant further increase with prolonged incubation times
(Fig.: 3 B2). Tissue relaxation was significantly reduced by the 6 h
treatment, a reduction that also plateaued at later time points
(repeated measures (RM) ANOVA, treatment time: p,0.001,
treatment group: p = 0.05) (Fig. 3 B3). We verified that the
observed mechanical effects were actually evoked by MGO
reaction with lysine and arginine [9,12,28], as confirmed by
effectively inhibiting the mechanical changes upon addition of
20 mM L-lysine and 20 mM L-arginine to the MGO cross-linking
solution (Fig. 3 B1 and B2).
Collagen fibril deformation under load – supramolecular
failure behavior
Collagen fibril failure behavior (as inferred from tissue level
failure behavior and corresponding measures of fibril level strain)
was heavily affected by MGO treatment with higher peak fibril
strain at tissue failure. The apparent fibril failure mode also
changed upon MGO treatment, with a more abrupt (‘‘brittle’’)
onset of collagen fibril disruption.
Collagen fibril deformation during tendon tensile loading was
measured at the coherent small-angle X-ray scattering beamline at
the Swiss Light Source, Paul Scherrer Institute, Switzerland. Two
experimental sets were measured, set 1: control (n = 9), 6 h MGO
(n= 10), 24 h MGO (n= 5) and set 2: control (n = 5), 6 h MGO
(n= 5). Collagen fibril deformation was measured as absolute and
relative increase of D-periodic length. Fibril deformation and fibril
strain was a highly linear function of tissue strain, although the
force-deformation response of collagenous connective tissues is
typically non-linear (Fig. 4 A and 5 C). In all groups, the
meridional collagen scattering peak width, measured as FWHM,
remained approximately constant up to yield point (Fig. 4 B3).
This indicates homogeneously distributed fibril strains [29]
(Fig. 2). After yielding a sudden broadening of the peak occurred,
indicating a more heterogeneous collagen fibril strain distribution
that reflects the onset of non-elastic (plastic) deformation and
damage accumulation with increasing numbers of ruptured fibrils
and disrupted inter-fibril matrix.
Collagen fibril stiffness – analysis of molecular strain and
sliding
Analysis of the molecular deformations within individual fibrils
revealed that sliding between neighboring collagen molecules was
heavily affected by MGO treatment, but that overall stiffness of
the fibrils was not altered.
To analyze the molecular mechanisms behind these observed
fibril level changes, we decomposed fibril elongation into
homogenous, affine molecule elongation (i.e. strain) and molecular
side-by-side sliding. The effect of molecular sliding was indicated
as a relative length change of gap and overlap regions (Fig. 2) [18].
Such changes in the ratio of gap to overlap and consequently the
overlap to D-period (O/D), can be observed as a change in relative
intensity (I of order n) of the meridional D-period reflections as
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when a simple two-phase arrangement is assumed with lower and
higher electron dense regions representing the gap and overlap in
the collagen fibril (Fig. 1 and 2 B) [18]. This assumption compares
well to more sophisticated models of axial collagen molecular
conformation [14,15,30]. The ratio of intensities of the 2nd and 3rd
order reflections were analyzed to assess changes in length of the
overlap region (O), with this ratio decreasing monotonically with
increasing fibril strain (Fig. 4 B1, Fig. 4 B2). This relative
shortening of the overlap region was less pronounced after
MGO treatment, and the onset of overlap shortening was delayed
until higher tissue strains. However, MGO treatment was also
accompanied by a shortening of the overlap region and the D-
period at pre-load.
Furthermore, 7 samples out of 15 in the 6 h MGO group
showed diffraction patterns with onset of peak splitting near
mechanical yielding of the tissue (Fig. 5). The splitting implies
Figure 1. Schematic of experimental principles. Left) 2D diffraction patterns from tendons are dominated by the meridional Bragg reflections
corresponding to ,67.5 nm and harmonic frequencies of this spacing. Right) This pattern results from the quarter-stagger model of collagen. More
simply, this can be seen as ‘‘gap’’ and ‘‘overlap’’ regions with high and low electron dense areas that scatter X-rays as wide periodic slits [63].Middle)
The meridional intensities were integrated over azimuthal (h) sectors, which resulted in 1-D intensity profiles, I [a.u.] vs. q [nm21]. The peak positions
or correspondingly the distance between peaks) were used to calculate the length of the periodicity (Bragg’s law) during tensile experiments.
Changes of the peak spacing served then as averaged measure for collagen fibril elongation: absolute deformation (D) and relative fibril strain).
doi:10.1371/journal.pone.0110948.g001
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onset of a bimodal distribution of collagen fibrils, with one
subpopulation representing mechanically loaded (and stretched)
fibrils and the other subpopulation in the distribution reflecting
fibrils in the processes of relaxing toward their unstressed length
[31]. In control tendons the diffraction pattern could not be
decomposed to the sum of two different Bragg reflections,
indicating a characteristically less abrupt mode of fibril damage,
characterized by a respective loss of the quarter-staggered
molecular arrangement.
The D-period length measured at a given level of applied pre-
stress (D0) was shorter in accordance with duration of the MGO
treatment (control: 67.760.04 nm; 6 h MGO: 66.8660.17 nm;
24 h MGO: 65.9160.07 nm; two-way ANOVA, treatment group
and time of treatment: p,0.001, all post hoc: p,0.001). For this
reason we relied on collagen fibril stiffness, a measurement based
on fibril deformation D, to discriminate the mechanical effects of
the treatment between groups and rather than relying on collagen
fibril modulus, which is based on fibril strain. This ensured that the
measurement for fibril elongation was not biased by the different
D0 length between groups.
Additional experiments were performed to estimate potential
biases related to cross-linking of the non-collagenous matrix (i.e.
cells, proteoglycans, elastin) and potential swelling artifacts (see:
Non-collagenous matrix characterization in Text S1). After
characterizing the mechanical properties of the non-collagenous
matrix, we used the rule of mixtures: s T= (1 - f) * sM+f * sF
[32,33], with an assumed collagen fibril area fraction of
f = 74.4%64.7% for all groups. The area fraction f is based on
a previous analysis of TEM micrographs, in which specific
attention was given to control against tissue swelling artifacts that
can occur during sample handling or treatment in aqueous
solutions [34]. We then used this equation together the mechanical
properties of the non-collagenous matrix (sM) from tensile tests in
direction transverse to the main fibril direction of equine digital
flexor tendons and assuming an isotropic homogenous matrix.
These revealed a negligible potential contribution of the non-
collagenous matrix to axial mechanical function, since the
maximal transverse stress in MGO treated samples was sM,
0.25 MPa. After excluding for these potential biases, the maximal
value of the numerical gradient of the collagen fibril stress (sF) as a
function fibril deformation, D, was used to estimate collagen fibril
Figure 2. Sketch of collagen fibril deformation and failure. A1)
Unloaded collagen fibrils. A2) With applied strain (blue arrows), the
collagen fibril D-periods increase homogenously and are approximately
equally long. This results in sharp peaks of the meridional collagen
reflections. A3) Post yielding, the collagen fibrils are deformed more
heterogeneously. This resulted in the broader peaks, measured as
FWHM. Some AGE samples this heterogeneity resulted in two distinct
populations of fibrils, which resulted in peak splitting. B1) Individual
collagen fibril from A1 composed of collagen molecules with shown D-
periodic pattern. B2) Apart from the molecule elongation the fibril
elongation consists of side-by-side sliding of collagen molecules, which
results in a decreased overlap (O) region, while the D-period increases
(not shown). This decreases the O/D ratio.
doi:10.1371/journal.pone.0110948.g002
Figure 3. Mechanical characterization of the tendon-AGE model. Row A: Stress-strain from the first experimental set. Except for the MGO
96 h group, these curves were measured simultaneously with the SAXS experiments. Row B: A selection of material properties extracted from row A:
B1) Elastic modulus was obtained in the linear range. Given are: mean (horizontal bar), percentile box (25% and 75%) and 61 SD. The specificity of
the MGO treatment was shown by the addition of L-lysine and L-arginine (LYS-ARG group) to the MGO solution and compared to MGO controls. For
ease of reading this control is not shown. B2) Ultimate tensile strength (UTS). B3) Separate stress relaxation experiment (n = 5) was performed with
repeated measurements on the same samples and compared to a corresponding control (n = 5). Stress relaxation is reported as: sR(175 s) = 1-
s(175 s)/s(0 s) [%].
doi:10.1371/journal.pone.0110948.g003
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Figure 4. Results from SAXS experiments. Row A) Collagen fibril stress) vs. D-period. Normalized collagen fibril stress was calculated using the
rule of mixtures. The numerical gradient (slope) of the D-period vs. collagen fibril stress curves was used to measure fibril stiffness. Peak stiffness was
used as the parameter for statistical interference testing. The second experimental set (w/o a 24 h MGO group) is not plotted here since over all the
stresses were approximately one third lower but with equal group effects (two-way ANOVA: interactions term, p = 0.531). B1) Ratio of the integrated
intensities for the 2nd and 3rd order meridional collagen reflections. B2) Relative contribution of overlap (O) region to the D-period (O/D) vs. D-period,
when assuming a two-phasic approximation of the D-period electron density [17,63]. B3) Peak widths (FWHM) from fitted Gaussians measured
during the tensile experiments vs. D-period length. Note: The grayed area in the insets represents the range of yield point of the control samples as
reference.
doi:10.1371/journal.pone.0110948.g004
Figure 5. Failure mode of collagen fibrils. A+B) Diffraction patterns recorded after yielding. A) A control sample. B) A 6 h MGO sample. The
corresponding 1D azimuthal averages are indicated by blue dots. The intensity range is scaled to show the full scale from the 3rd diffraction peak.
Peaks were fitted to Gaussian functions (red). In some MGO samples the best fit was bimodal Gaussian (green) in account of the peak splitting as the
sum of two Gaussians (red). The first peak is not shown. C) Stress-strain curve of a MGO sample that showed peak splitting shortly after yielding (grey
horizontal bar). The gradient of the stress-strain curve, which is a local estimate of elastic modulus, is also shown. D-period estimates of the same
sample is also shown (3rd reflection), with the loaded and deformed collagen fibrils (¤) and the more relaxed ones (e).
doi:10.1371/journal.pone.0110948.g005
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stiffness, with units of MPa/nm, a departure from the standard
definition of microstructural stiffness, e.g. mN/nm (Fig. 4 A). In
conclusion, collagen fibril stiffness remained unaffected by the
treatment (control: 39.9614.7 MPa/nm; 6 h MGO: 39.76
5.6 MPa/nm; 24 h MGO: 36.263.9 MPa/nm; two-way AN-
OVA: experimental set and treatment: p = 0.611) (Fig. 4 A). This
is in contrast to the tissue level mechanical properties where the
elastic modulus notably increases by 35%. To provide a basis for
comparison to the literature, we additionally calculated the
collagen fibril modulus of all samples: 2.4660.64 GPa.
Collagen fibril viscoelasticity
Treatment by MGO drastically reduced collagen fibril stress
relaxation. To assess collagen fibril viscoelasticity incremental
stress relaxation was performed from 0% and 3% nominal strain
(tissue strain, eT) in increments of DeT=0.6% (control: n = 10 and
6 h MGO: n=10) (Fig. 6). We tested only the 6 h MGO group in
combination with SAXS, since the reduction in viscoelasticity was
constant beyond 6 h of treatment as mentioned before (Fig.: 3 B3).
Collagen structures of rat tail tendons display two-stage relaxation
kinetics at all levels of structural hierarchy [16,35]. Thus the
averaged tissue stress relaxation (sR) and collagen fibril relaxation
(eR) were fitted by a double exponential decay for each step of
relaxation:
sR(t)~DsR,1exp
{t
ts,1
 
zDsR,2exp
{t
ts,2
 
zDsR,?
and
eR(t)~DeR,1exp
{t
te,1
 
zDeR,2exp
{t
te,2
 
zDeR,?
where DeR,1, DeR,2, DsR,1 and DsR,2 are fitted parameters and
DeR,‘ and DsR,‘ correspond to the values at t = infinity. The two
term exponential fits were highly reliable for both groups in stress
relaxation and for controls in fibril relaxation (R2.0.99) and
consistently better than one term exponentials. Slightly smaller
values were found for fibril relaxation of the 6 h MGO group
(R2= 0.78–0.99) due to small changes in relaxation compared a
relatively larger variability. In conclusion, the results indicate that
relaxation was drastically diminished but the characteristic two-
phase behavior remained after MGO treatment when comparing
values at comparable fibril elongation: For example at D>68 nm,
which corresponds to the strain increment: e T= 1.8% for controls
and: eT=3.0% for 6 h MGO, the relaxation times (ts, te)
remained very similar and only the magnitudes (DsT, DeF)
decreased by the MGO cross-linking (Table 1).
Finally, collagen fibril viscoelasticity was observed to be
markedly diminished in MGO treated samples at higher levels
of strain. To make this analysis we first approximated an
‘‘instantaneous’’ modulus (Dsb/Deb) at the beginning (b) of the
relaxation increment. This measure was intended to capture both
elastic and viscous effects, even though it is a crude approximation
given the finite tissue strain-rate that was applied (0.5% eT s
21).
Similarly, the elastic or ‘‘equilibrium’’ modulus was calculated
(Dse/Dee) using values from the end (e) of the relaxation
increment. This equilibrium modulus is again a crude approxi-
mation given the clearly non-infinite relaxation time of 175 s.
Using these approximate measures, we observed a small and very
similar viscous response in both groups at lower strains (eT= 0.6–
1.2%), since the elastic fibril modulus was roughly 5% less than the
total modulus in both groups (RM ANOVA, elastic contribution:
p = 0.017, treatment group: p= 0.13). However, with increasing
strains (eT=1.2–1.8%) the viscous component increased in
controls to approximately 10% and decreased to approximately
2% in the MGO group (RM ANOVA, elastic contribution:
p = 0.024, treatment group: p = 0.072). At higher strains, post yield
point, the controls began partially to fail, precluding additional
analysis.
Evidence of AGEs formed by MGO
In order to obtain insight into the type of modifications resulting
from MGO, fascicle collagens were subjected to enzymatic
digestion with papain to measure the acid labile fluorescence
and acid hydrolysis to measure selected acid stable modifications
of lysine and arginine residues.
Formation of acid labile AGEs was first confirmed by a
fluorometric assay (excitation wavelength: 370 nm, emission
wavelength: 440 nm) after enzymatic papain digestion and
normalization against a quinine sulfate standard row (see:
Collagen fluorescence and AGE quantification in Text S1)[26].
AGE concentration in the tissue significantly increased across all
analyzed time points and followed a first order rate equation
(ANOVA and all post hoc: p#0.044) (Fig. S1).
Analysis of arginine and lysine residue content in the acid
hydrolysate was then made by LC/MS/MS using an isotope
dilution technique. This analysis revealed profound losses of
arginine residues (Fig. 7 A), very consistent with AGE formation.
About 85% were modified by 6 h of incubation with 30 mM
MGO. The MGO hydroimidazolone MG-H1, an arginine AGE,
accounted for about 30% of lost arginine residues, but more likely
60% since it is partly destroyed during acid hydrolysis (Fig. 7 B).
Thus, some 40% of the losses are unaccounted for, but are likely
the result of degradation products of the acid labile lysine-arginine
cross-link MODIC [36] and the arginine adducts N(delta)-(4-
carboxy-4,6-dimethyl-5,6-dihydroxy-1,4,5,6-tetrahydropyrimidin-
2-yl)ornithine (THP) as well as argpyrimidine [37]. In contrast
only 10 to 15% of total lysine residues were lost from which about
50% (8 nmol) are attributable to acid stable MGO lysine adduct
carboxyehtyl-lysine (CEL). The remaining portion is likely due to
the lysine-lysine cross-link MOLD [38]. Among other AGEs and
glycation modifications that were measured but found unchanged
are furosine (fructose-lysine) and carboxyethyl-lysine (CML).
Discussion
Collagen cross-linking by AGEs has been increasingly implicat-
ed as a central factor in the onset and progression of connective
tissue disease [7–11]. For the first time we report the physical
effects of AGEs on collagen molecular and supramolecular
deformations under load. We identify and describe altered damage
mechanisms that could play a central role in connective tissue
disease processes. Our data provide evidence that accumulation of
AGEs dramatically affects collagen fibril failure behavior and
stress relaxation. These functional parameters strongly reflect how
collagen structures accommodate mechanical load and overload.
Because the temporal and spatial dynamics of connective tissue
damage and repair involve an intricate balance of mechanically
driven catabolic and anabolic processes, even slight changes in
collagen mechanics or patterns of damage accumulation may
detrimentally affect tissue homeostasis. Such changes in extracel-
lular matrix mechanics are likely to be exacerbated by resistance of
AGE modified substrates to proteolytic enzymes that drive and
regulate balanced matrix remodeling, or by chronic activation of
inflammatory mediators that drive fibrosis [39].
Glycation End-Products and Collagen Mechanics
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We selected the metabolite MGO to rapidly induce the
formation of AGEs in type-I collagen fibrils on the basis that
MGO chemistry is well known and that MGO induced AGE
formation is both rapid and well understood [28,36–38]. While in
vitro models of AGE formation have employed a variety of buffers
containing different sugars or carbonyls, these models collectively
show consistent effects on both structural [40] and mechanical
parameters [2,3,24]. It should be noted that the high MGO
concentrations of up to 30 mM used in the present study clearly
exceed physiological levels. Nevertheless, the mechanical changes
we observed are in close agreement to the limited experimental
evidence in the literature using a streptozotocin-induced diabetic
model [41].
We determined an equivalent collagen fibril modulus of
2.5 GPa in both MGO modified specimens and controls - a key
finding that contrasts with the current and commonly held belief
that age-related modifications by AGEs increase collagen supra-
molecular stiffness. The modulus value of our controls is in close
agreement to similar values reported by others for native collagen
fibrils [18,31,35,42–44]. Our results further agree with recent
molecular modelling studies predicting an independence of fibril
stiffness from enzymatic cross-links up to 30% strain if a minimum
number of cross-links are in place [21,45]. This model predicts
Figure 6. Row A) Averaged (±1 SD) tissue stress–time relations from consecutive relaxation increments of size =0.6% L0: A1)
Control samples (n=10). A2) 6 h MGO group (n = 10). A3) The corresponding total stress decay. Row B) Collagen fibril relaxation defined as
relative length change of the D-period during relaxation steps: B1) Controls B2) 6 h MGO. B3) The corresponding total change in fibril length.
doi:10.1371/journal.pone.0110948.g006
Table 1. The parameters and upper (UCI) and lower (LCI) 95% confidence intervals that were fitted to the stress and fibril
relaxation at comparable fibril elongations.
Stress relaxation Fibril relaxation
Control group 6 h MGO Control group 6 h MGO
Fitted parameters D???R,1 [Mpa] 2.4 0.68 DeR,1 [%] 0.16 0.032
LCI 2.3 0.65 LCI 0.15 0.027
UCI 2.5 0.71 UCI 0.17 0.040
t???,1 [s] 60 64 te,1 [s] 75 68
LCI 49.0 53 LCI 61 33
UCI 71 76 UCI 90 99
D???R,2 [Mpa] 1.1 0.37 DeR,2 [%] 0.06 0.019
LCI 1.0 0.33 LCI 0.05 0.014
UCI 1.2 0.41 UCI 0.07 0.024
t???,2 [s] 2.8 2.9 te,2 [s] 4.1 3.8
LCI 2.0 2.3 LCI 3.1 1.5
UCI 3.5 3.6 UCI 5.2 5.1
D???R,‘ [Mpa] 8.8 19.6 DeR,‘ [s] 0.77 0.95
LCI 8.7 19.7 LCI 0.76 0.94
UCI 8.9 19.6 UCI 0.78 0.96
R2 0.99 0.99 R2 0.99 0.99
doi:10.1371/journal.pone.0110948.t001
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that only at strains larger than 30% will increased LOX cross-link
density lead to higher moduli and more abrupt failure modes,
resulting primarily from less molecular sliding. In this sense, the
stochastically formed AGE investigated in the present experimen-
tal study suggest a similar but substantially earlier mechanical
onset of the effects described in the theoretical investigations of
enzymatic crosslinking in tissue development. However, we were
unable to measure strains as large as those simulated by the model
since SAXS experiments on collagen fibrils requires that tissues
must retain an intact quarter-staggered conformation to yield a
signal suitable for calculating fibril strain. Nevertheless, we found
that MGO modified fibrils could be elongated to a higher extent
before onset of material yield: controls: ,3.5% fibril strain vs.
MGO: ,5.7% fibril strain, as predicted by numerical models of
enzymatic crosslinking. MGO modification also reduced molec-
ular side-by-side sliding and the fibril remained in an intact
quarter-staggered conformation to higher levels of tissue strains.
We thus conclude that elastic deformation of the collagen
molecules was promoted by MGO induced AGEs.
Another important finding was the characterization of distinctly
different failure behavior in MGO treated specimens, with
dramatically increased collagen fibril strength and a shift to an
abrupt mode of failure. These conclusions should be considered in
view of the fact that fibril failure properties could only be inferred
from tissue level mechanics and SAXS based measurements of
fibril strain. Nonetheless, post yield failure in MGO treated
tendons was characterized by appearance of distinct subpopula-
tions of unloaded fibrils among (still intact) mechanically loaded
fibrils. This indicates that some fibrils fractured at a location
somewhere along their length with the remaining length of these
fibrils remaining in an intact quarter-staggered arrangement.
Given that the D-period length of the fractured fibril subpopu-
lation did not relax completely back to an unloaded state, they
apparently remain slightly stretched, probably due to lateral
connections to adjacent fibrils that were still under load. This
parallels observations from mechanical tests within diabetic rat
tissues, in which distinct failure behavior in these tissues has been
demonstrated to be a consequence of increased lateral inter-
connectivity across multiple collagen fibrils that simultaneously fail
[46]. This is in contrast to failure behavior of native samples,
where signal intensities decreased after yielding without any peak
splitting, indicating either a thinning of the sample or more likely
the loss of quarter-staggered organization.
A third key finding is that MGO treatment reduces inherent
collagen fibril viscoelasticity. Our previous work has shown that
MGO treatment inhibits tendon stress relaxation [26], which is
thought to be mainly governed by collagen fiber shear and sliding
[16]. The results from the present study indicate that a reduced
fibril viscoelasticity may also be a substantial factor in the loss of
viscous response at the fiber level and the related shear matrix.
However, it remains unclear how nano-scale effects of AGE could
translate to mechanical effects across these different orders of
magnitude in scale. An eventual involvement of AGE altered fibril
surface charges [47] can in principle change the viscoelastic
mechanical properties of soft tissue [48]. Comparing our
observation of AGE mediated loss of fibril viscoelasticity to others,
Svensson and colleagues found no mechanical differences in single
fibrils from diabetic rats (Zucker diabetic fat) and that the
investigated biochemical markers of AGE remained equal to
controls [42].
Considering what is known from the biomaterials field
regarding chemical cross-linking of collagen constructs, Yang
and colleagues have described distinct effects on single collagen
fibril viscoelasticity using cross-linking reagents of different cross-
linking length [35]. With the ‘‘zero length’’ cross-linker EDC (1-
Ethyl-3-(3-dimethylaminopropyl)-carbodiimide) there was no
change of fibril modulus found aside from an increased failure
behavior and a reduced viscoelasticity, which echoes the results of
the present study (Fig. S5). In contrast, glutaraldehyde formed
cross-links have a length of least 1.3 nm length [35,49] that can
bridge across micro-fibrils, and glutaraldehyde treatment has been
shown to increase fibril modulus [35]. Based on these observation
we hypothesize that the lack of an increased fibril modulus in
MGO cross-linked tendon is due to its shorter cross-linking length
in the range from 0.26 nm to 0.70 nm [22,50].
There are some potential weaknesses of this study. First, despite
clear increases in fluorescence and denaturation temperature [26]
after the applied treatment we have not provided direct molecular
evidence for cross-linking by MGO, although extensive MOLD
and MODIC formation has been documented in the course of
protein incubation by methylglyoxal [51]. Secondly, while we
suspect that the fibril shell is more susceptible to AGE modification
than the fibril interior [52], the data we present preclude any
meaningful analysis of AGE location and conjecture regarding
where they form on the basis of our data would be speculative at
best. Thirdly, concerning the physiological relevance of the
Figure 7. Top) The effect of 30 mMMGO on lysine and arginine
content on collagen, normalized to collagen mass measured
with a hydroxyproline assay and assuming 14% hydroxypro-
line per collagen. Averages are given with61 SD. Bottom) Effects of
the MGO treatment on selected AGEs normalized by collagen content.
doi:10.1371/journal.pone.0110948.g007
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employed in vitro AGE model, the high MGO concentrations
used in this study were decidedly non-physiological and are to
some extent analogous to the use of glutaraldehyde as a fixative
agent. Finally, we cannot exclude the possibility that acute cross-
linking by MGO could non-physiologically alter multi-scale shear
transfer mechanisms in the non-collagen matrix. Although, our
experiments investigating the load bearing capacity of the non-
collagen matrix indicated that contribution of these AGE modified
matrix components (mechanical properties when the tendon is
tested transverse to the functional axis of the tissue) to tissue
strength was minimal. In vivo, the cells and non-collagen matrix
would be less susceptible to AGE accumulation given their
relatively short half-life in comparison to type-I collagen [13]. We
nonetheless accept these limitations that accompany the employed
in vitro AGE model, which avoids critically confounding effects
(i.e. collagen loss) in comparative models of endogenous AGE
formation.
Generally, our use of the D-period length as a proxy measure of
fibril deformation and estimates of gap and overlap length agree
well with reported values from previous SAXS experiments
[14,15,18,19,53]. Fibril strains were always less than the applied
tissue strains. The ratio of fibril to applied strain was 0.6, which is
considerably higher compared to previously reported values of 0.4
[19,54]. We attribute this difference to the at least 5-fold higher
strain-rate used in the present work compared to previous studies,
which minimized viscoelastic effects over the time course of the
experiment. More interestingly however was the fact that this ratio
increased to 0.75 when the applied tissue strain (based on grip-to-
grip displacements) was corrected to an estimate of mid-substance
strain (for the relation of grip-to-grip tissue strain versus tissues
strain based on optical markers see: Correction for local-optical
strain measurements in Text S1) that corrects for deformation
‘‘artifacts’’ at the clamps. We also note the similarity of our
collagen fibril relaxation data to Gupta and colleagues [16]. This is
particularly interesting, since their results come from a single
relaxation experiment per sample, in contrast to the present work
in which each sample underwent multiple relaxations across a
range of strain levels. Thus collagen fibril relaxation seems to be at
least partly independent of strain history.
In conclusion, our data reveal that MGO-induced AGEs reduce
inherent collagen fibril viscoelasticity and alter fibril failure mode.
We attribute these changes in viscous response and failure to
altered molecular sliding as measured in the present study. We also
conclude that tensile stiffness (modulus) changes in tissue are not
due to an increased stiffness at the fibril level, and conclude that
this must largely be due to changes in higher collagen structures
[26]. Collectively these findings add considerable precision to the
very general clinical observation that connective tissue mechanical
properties change with age and diabetes. These findings also
sharpen focus on the range of possible vectors by which AGE
accumulation in collagen tissue is likely to affect tissue homeostasis
and drive tissue pathology.
Experimental Procedures
Sample preparation and AGE induction
Tails from skeletally mature Sprague-Dawley rats (17 to 24
weeks) were removed after sacrifice and stored (218uC) until the
day of experiment, which should not have an effect on tendon
mechanics [55]. Rats have been euthanized by carbon dioxide
inhalation for an unrelated study. Rats were handled in strict
accordance with Swiss regulations for animal studies according to
the Federal Food Safety and Veterinary Office. The study was
previously approved by the ethics committee of the Canton Zurich
Veterinary Office. For each set of experiment the age of the
animals was matched. Individual fascicles were dissected and
mounted in poly-sulfone clamps followed by area measurements at
a pre-stress of 1.5 MPa (details follow). AGEs were induced by
incubation at 36uC with 5 ml of 30 mM MGO (see: Synthesis of
high quality methylglyoxal in Text S1) buffered with 100 mM
EPPS (4-(2-Hydrox-yethyl)-1-Piperazinepropanesulfonic acid) in
PBS (pH=8) containing protease inhibitors (1 mM EDTA, 2 mM
AEBSF, 130 mM betastatin, 14 mM E-64, 1 mM leupeptin and
0.3 mM aproptin). Mechanical tests after treatment with MGO in
phosphate buffered saline (PBS, pH=7.4) indicated equal effects.
Finally, the reaction of MGO was ceased by multiple washing
steps in copious amounts of PBS on ice for at least 2 h. The
specificity of the treatment effects was investigated by incubations
in presence of L-arginine (20 mM) and L-lysine (20 mM). A
fluorometric assay was used to measure collagen associated
fluorescence (see: Collagen fluorescence and AGE quantification
in Text S1)[24].
Determination of advanced glycation end-products
After treatment tendons were washed with water and extracted
with 2:
1 chloroform-methanol for 24 h followed by rehydration with
water and freeze-dried. Approximately 1 mg of each sample was
acid hydrolyzed in 1 ml of 6 M HCl under nitrogen for 16 h at
110uC. The acid was evaporated by a speed-vac concentrator
(Thermo-Fisher) followed by reconstitution of the material in
0.5 ml water and filtered (0.45 mm filter, Spin-X, Corning Costar).
The collagen content was determined by the hydroxyproline assay
[56]. Aliquots of 100 mg collagen were spiked with isotopocially
labeled internal standards and analyzed by injection of 40 ml
(,40 mg) into a high-performance liquid chromatography - mass
spectrometer (HPLC-MS/MS) for lysine, arginine, MGO hydro-
imidazolone (MG-H1) and carboxyethyl-lysine (CEL) as previous-
ly described [57].
Biophysical characterization of the AGE-tendon model
Tendon fascicles were quasi-statically tested in uniaxial tension
in a custom climate chamber containing PBS placed on a universal
testing machine (Zwick, Z010 TN, 20 N load-cell, Germany). The
initial length of the sample (L0) was measured from clamp-to-
clamp at a pre-stress of 1.5 MPa (Fig. S2). At this point, two digital
photographic images from orthogonal perspectives were taken
(Telecentric lenses: Carl Zeiss, Visionmes 16/1/1, Germany;
Cameras: iDS, UI-5250CP, pixel size: 4.5 mm, Germany) to
characterize the area (minor diameters of the ellipsoid shaped
fascicle $180 mm)[34,55]. Tissue strain was defined as nominal
strain: eT= (L – L0)/L0 [%] (for a comparison to optical markers
derived strains see: Correction for local-optical strain measurements
in Text S1). Before all mechanical tests, tendons were precondi-
tioned up to 1.5% L0 until stress-strain curves were congruent.
Subsequently, relaxation or ramp to failure experiment was
conducted with constant strain-rates (0.5% L0 s
21). The force
readings were normalized to (nominal) tissue stress (sT) by the pre-
treatment sample area. Normalized stress relaxation was defined
as sR(t) = 1- s(t)/s(0) [%], with s(0) being the stress at start of
each relaxation step and the time (t) ranging from 0 to 175 s. The
tissue mechanical properties were described by elastic modulus in
the linear range of the stress-strain relation using linear regression.
Onset of plastic deformation, yield point, was estimated using a
0.2% L0 offset of the regression line in the linear part of the stress-
strain curve. Tissue failure was characterized by ultimate strength
(UTS) and the corresponding strain [58–60]. MGO significantly
shortened the sample length at pre-stress of 1.5 MPa by 3%
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(ANOVA: p= 0.049), leading to a slight corresponding underes-
timation of elastic modulus in cross-linked samples by approxi-
mately 3%. This bias was considered to be negligible compared to
the observed effects and was therefore not considered.
Synchrotron X-ray scattering measurements
Frozen tails were stored on dry ice for transportation to the
beamline facilities and then stored at 218uC until testing.
Preliminary experiments indicated no changes in the mechanical
properties of the tissue. Following sample preparation, as
described before, fascicle-clamp assemblies were mounted on a
custom-built tensile testing apparatus (linear stepper motor:
NA23C60, accuracy 40 mm, Zaber Technologies Inc., Canada;
load cell: KD24S, 20 N, accuracy: 0.1%, Transmetra, Switzer-
land) with a custom-designed control software (LabVIEW). An x-y
table was used to adjust the axial sample alignment. The tensile
tester was a modification of an available micro-compression device
[61], which was designed to fit on the stage of the coherent small-
angle X-ray scattering (cSAXS) beamline at Swiss Light Source
(Paul Scherrer Institute, Switzerland). During all experiments two
30 mm Kapton films (X-ray semitransparent material) were placed
on two sides of each tendon held together by a drop of PBS to
maintain tissue hydration (Fig. S3)[16].
To measure collagen fibril deformation we used SAXS with an
X-ray wavelength of 0.1 nm obtained from a double-crystal
Si(111) monochromator and a beam cross-section at the sample
300 mm width and 200 mm height obtained by slight focusing
using the bendable monochromator crystal and high-order
rejection mirror. The specimens were placed ,12 mm upstream
the entrance window of an evacuated 7.03 m flight tube. 2D
diffraction patterns were recorded with PSI developed PILATUS
2M detector (array size: 147561679 pixels; pixel size:
1726172 mm2; active area: 2546289 mm2) [62]. The total sample
to detector distance (7.158 m) and the center of the direct beam on
the detector were calibrated using silver behenate. The SAXS
frames were collected with an acquisition time of 200 ms
concurrently during mechanical testing with the detector being
triggered by the testing apparatus. During each relaxation step
(subsequent tissue strain increments of DeT= 0.6% L0) frames
were acquired at exponentially increasing time intervals. This
exponential curve matched previous published collagen fibril
relaxation by Gupta [16] and allowed an optimal acquisition of
data where collagen deformation occurred. A shutter closing
between frames reduced the X-ray dose at the sample (for the
effect of X-ray irradiation on the experimental measures see Fig.
S4).
SAXS data analysis
The collected 2D SAXS patterns showed the 1st to 12th order
meridional collagen reflections. Azimuthal integration was carried
out over angular sectors of 45u width centered at the calibrated
location of the direct beam on the detector. From the resulting 1D
intensity profiles [a.u.] versus q [nm21] (Fig. 5 A) a two-term
exponential background was subtracted (empirically determined
best fit). The peak position, height and width (FWHM) were
estimated by fitting a series of Gaussian curves to the first 8 order
collagen reflections using non-linear least squares (OriginPro 8.6;
Matlab R2013a). A straight line, q(n) = a+b * n, was fitted through
the peak positions q(n) as a function of the order number (n) [16].
The collagen fibril D-spacing was calculated from D=2 p/b. The
precision of measuring the D-period was 0.24%. Precision was
measured at pre-stress and is given as the upper 95% confidence
interval of the coefficient of variation from 26 samples. Either
absolute or normalized change of D-spacing served as averaged
measures of collagen fibril elongation: collagen fibril deformation/
lengthening (D) and collagen fibril strain (eF =D/D0–1 [%]) with
D0 as D-period length at pre-stress/start of experiment. For each
relaxation step, collagen fibril relaxation was measured as the
relative shortening of D normalized to the D at start of each
relaxation step (D0): eR=D/D0–1 [%]. Collagen fibril deforma-
tion as a function of tissue strain was highly linear up to at least
yield point (Fig. 5 C) and therefore fitted by 1st order polynomials
to calculate fibril stiffness. Force measurements were smoothed
using a moving average filter of 20 points to reduce noise of the
data recorded at 100 Hz.
Statistical analysis
Parameters derived from the experiments were analyzed using t-
tests (factor: treatment group), one-way ANOVAs (fixed factor:
treatment group), two-way ANOVAs (fixed factor: treatment
group and experimental set) or RM ANOVAs (fixed factor:
treatment group, repeated measures factor: time of treatment).
Post hoc pairwise comparisons were made with adjusted p-values
(Dunnett’s test for treatment vs. control, Tukey-Kramer test for all
pairwise comparisons with unequal sample sizes). Unless otherwise
stated, results are reported as averages and standard deviations (1
SD). Two-sided tests were used and p-values of 0.05 were chosen
as the level of significance, if not stated otherwise. Corresponding
non-parametric counterparts were used when model assumptions
were not met (SPSS v21.0/Matlab R2013a/OriginPro 8.6).
Supporting Information
Figure S1 Results from collagen fluorescence and AGE
fluorometric measurements. Accumulation of AGEs in
tendon specimens after 0 h, 6 h, 24 h and 96 h of incubation in
MGO. Each data point, respectively sample, was measured thrice
and averaged (relative precision: coefficient of variation = 7%).
(TIF)
Figure S2 A) A measurement of grip-to-grip/machine
strain vs. mid-substance tissue strains. The relationship
was highly linear and could therefore be well approximated by a
line (least square fitting) and reduced to one measure (ratio: eO/
eT) that could be used to correct all measurements. B) A tendon-
clamp assembly in the fixation rig. The white paper was used to
increase the friction at the clamps. Before each test dark markers
were gently applied for optical strain measurements.
(TIF)
Figure S3 Consecutive force-strain cycles from one
sample out of 5, that were used to control for any biases
on sample mechanics when using the Kapton mini-
climate chamber (either due to evaporation of the PBS
and corresponding sample dehydration or due to
directly affecting the force reading). To clearly separate
the effect of dehydration from normal sample mechanics, the
sample was also tested after drying for 30 min on air.
(TIF)
Figure S4 Effects of X-ray irradiation (12.4 keV) of one
exemplar sample. The gray area indicates the maximal
irradiation time that a sample was exposed to during any
mechanical experiments. A) The calculated D-period lengths are
shown for the first eight order collagen reflections. The higher the
D-period value, the lower the order of the reflection. One can
observe the systematic error of measuring the D-period by the
slight differences in values from different orders, which is a result
probably of a slight asymmetry in the lower order peaks, mainly 1
and 2. B) Shown are the intensities from these different ordered
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reflections. These radiation effects were irreversible, unless we
repeated the experiments at a different spot on the tendon.
(TIF)
Figure S5 Normalized stress relaxation with sR(t) as
the stress at time (t) and sR(0) the stress at start of the
relaxation. Control and 6 h MGO are stress relaxation
experiments at similar collagen deformation levels (68 nm) and
are taken from the present study. For comparison values from
single collagen fibril relaxation are taken from Yang et al. [35].
They also fitted their data with two exponentials. The fitted
parameters were taken and plotted here (green).
(TIF)
Text S1 Supporting Information Methods.
(DOCX)
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